HCPCS J9064 — Inj, cabazitaxel (sandoz) (2026 RVU Values)
HCPCS code J9064 (Inj, cabazitaxel (sandoz)) is published in the 2026 CMS Physician Fee Schedule. Use this page as a reference for billing, productivity tracking, and compensation modeling.
How Medicare handles HCPCS J9064
Medicare status: Drug-priced (ASP). This code is paid based on the Average Sales Price (ASP) of a drug or biological, not on RVUs. It does not add work RVUs; the administration code billed with it usually does.